ACE2 and COVID-19: Some studies suggest that the expression of angiotensin-converting enzyme 2 (ACE2) receptors of SARS-CoV-2 in cardiac myocytes is responsible for the relatively high cardiovascular involvement in COVID-19 [7,8].